Gentiopicroside
Cat.No:IG0510 Solarbio
CAS:20831-76-9
Molecular Formula:C16H20O9
Molecular Weight:356.32
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > GentiopicrosideCAS:20831-76-9
Molecular Formula:C16H20O9
Molecular Weight:356.32
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 20831-76-9 |
| Name | Gentiopicroside |
| Molecular Formula | C16H20O9 |
| Molecular Weight | 356.32 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 244-070-2 |
| MDL | MFCD00075700 |
| SMILES | C=C[C@@H]([C@@H]1O[C@]([C@@H]([C@@H](O)[C@@H]2O)O)([H])O[C@@H]2CO)C(C3=CO1)=CCOC3=O |
| InChIKey | DUAGQYUORDTXOR-GPQRQXLASA-N |
| InChI | InChI=1S/C16H20O9/c1-2-7-8-3-4-22-14(21)9(8)6-23-15(7)25-16-13(20)12(19)11(18)10(5-17)24-16/h2-3,6-7,10-13,15-20H,1,4-5H2/t7-,10-,11-,12+,13-,15+,16+/m1/s1 |
| PubChem CID | 88708 |
| Target Point | Cytochrome P450 |
| Passage | Metabolic Enzyme&Protease |
| Background | Gentiopicroside is an iridoid glycoside that inhibits P450 activity. |
| Biological Activity | Gentiopicroside 是一种天然的环烯醚萜苷,能够抑制 P450 的活性,对 CYP2A6 的 IC50 和 Ki 值分别为 61 μM 和 22.8 μM;Gentiopicroside 具有抗炎和抗氧化活性[1-3]。 |
| IC50 | 61μM(CYP2A6)[1] |
| Data Literature Source | [1]. Deng Y,et al. In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6. Drug Metab Pharmacokinet. 2013;28(4):339-44. Epub 2013 Feb 19. [2]. Yang Y,et al. Protective effect of gentiopicroside from Gentiana macrophylla Pall. in ethanol-induced gastric mucosal injury in mice. Phytother Res. 2018 Feb;32(2):259-266. [3]. Chen F,et al. Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways. Biomed Pharmacother. 2018 Apr;100:142-146. |
| Unit | Bottle |
| Specification | 20mg 10mM*1mL in DMSO 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download